Adverum Biotechnologies Net Income
| ADVMDelisted Stock | USD 4.36 0.00 0.00% |
As of the 30th of January, Adverum Biotechnologies shows the Risk Adjusted Performance of 0.0479, downside deviation of 0.875, and Mean Deviation of 0.8383. Adverum Biotechnologies technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Adverum Biotechnologies variance, value at risk, as well as the relationship between the Value At Risk and skewness to decide if Adverum Biotechnologies is priced correctly, providing market reflects its regular price of 4.36 per share. Given that Adverum Biotechnologies has jensen alpha of 0.063, we suggest you to validate Adverum Biotechnologies's prevailing market performance to make sure the company can sustain itself at a future point.
Adverum Biotechnologies' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Adverum Biotechnologies' valuation are provided below:Adverum Biotechnologies does not presently have any fundamental signals for analysis. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools. Adverum |
Search Suggestions
| AD | Array Digital Infrastructure | Company |
| ADC-PA | Agree Realty | Company |
| ADX | Adams Diversified Equity | Fund |
| ADZ | Deutsche Bank | ETF |
| ADVN | NYSE Advancing Stocks | Index |
| ADX | ADX | Cryptocurrency |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Adverum Biotechnologies reported net income of (130.93 Million). This is 138.36% lower than that of the Biotechnology sector and 286.92% lower than that of the Health Care industry. The net income for all United States stocks is 122.93% higher than that of the company.
Adverum Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Adverum Biotechnologies' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Adverum Biotechnologies could also be used in its relative valuation, which is a method of valuing Adverum Biotechnologies by comparing valuation metrics of similar companies.Adverum Biotechnologies is currently under evaluation in net income category among its peers.
Adverum Fundamentals
| Return On Equity | -4.18 | |||
| Return On Asset | -0.77 | |||
| Current Valuation | 159.14 M | |||
| Shares Outstanding | 22.08 M | |||
| Shares Owned By Insiders | 13.21 % | |||
| Shares Owned By Institutions | 88.30 % | |||
| Number Of Shares Shorted | 811.4 K | |||
| Price To Earning | (2.10) X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 94.37 X | |||
| Revenue | 1000 K | |||
| Gross Profit | (77.12 M) | |||
| EBITDA | (135.51 M) | |||
| Net Income | (130.93 M) | |||
| Cash And Equivalents | 235.84 M | |||
| Cash Per Share | 2.37 X | |||
| Total Debt | 91.7 M | |||
| Debt To Equity | 0.43 % | |||
| Current Ratio | 8.03 X | |||
| Book Value Per Share | (2.53) X | |||
| Cash Flow From Operations | (92.46 M) | |||
| Short Ratio | 0.93 X | |||
| Earnings Per Share | (8.57) X | |||
| Target Price | 4.88 | |||
| Number Of Employees | 155 | |||
| Beta | 0.87 | |||
| Market Capitalization | 96.26 M | |||
| Total Asset | 179.84 M | |||
| Retained Earnings | (1.07 B) | |||
| Working Capital | 108.4 M | |||
| Current Asset | 260.99 M | |||
| Current Liabilities | 6.57 M | |||
| Net Asset | 179.84 M |
About Adverum Biotechnologies Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Adverum Biotechnologies's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Adverum Biotechnologies using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Adverum Biotechnologies based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Other Consideration for investing in Adverum Stock
If you are still planning to invest in Adverum Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Adverum Biotechnologies' history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |